Metabolic-Fit / 100
Omzo review
The homepage advertises semaglutide "starting at $179". The Terms and Conditions publish the actual schedule, and it says the follow-up months cost $299 — and that $179 is the price this program used to charge, superseded by a first month of $199. A rise written in the grammar of a discount. The tirzepatide figure is worse: the $279 on the homepage does not appear in the schedule at all, in any position.
then $299/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Omzo at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $399/mo
- Coverage
- All 50 states
- Brand-name
- Yes
How we scored Omzo
Every factor comes from Omzo's own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable or sits at the premium end.
General postpartum awareness, but no dedicated maternal guidance.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- August 2026
- Confidence
- high
- Primary source
- omzo.com
Read on 18 August 2026, and the figures come from the Terms and Conditions rather than the marketing pages, because that is the only place the schedule exists. Compounded semaglutide is $299 a month after a $199 first month; tirzepatide is $399 after $349. Brand-name Ozempic and Zepbound are $1,299 and $1,399 a month, initial and follow-up alike, each described as covering consultation, prescription, medication and shipping. Three things about how those prices are advertised. The homepage's "starting at $179" is 40% below the standing rate. The Terms describe $179 as the ORIGINAL price and $199 as the current one, which is a rise written in the grammar of a discount. And the homepage's "$279" for tirzepatide appears nowhere in the schedule in any position. To its credit, the same document is unusually plain about compounding: it states that compounded drugs are not FDA-approved, that the FDA does not review them for safety, efficacy or quality, and that it makes no claim of equivalence to any approved drug. It serves all 50 states, carries a LegitScript seal, names no operating entity and no compounding pharmacy, and has no FDA warning letter.
What to expect when you sign up
We walked Omzo's public signup funnel (August 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1The signup call to action stays on omzo.com (https://www.omzo.com/quiz-v2)
What we noticed
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $199 → $299 | Follow-up months — the standing rateThe Terms publish "Follow-Up Consultation - GLP-1 ... Priced at $299", with the first month at $199. ⛔ The homepage advertises "Starting at $179" — a figure the Terms describe as the ORIGINAL price, now superseded by a higher one. |
| Compounded tirzepatide | $349 → $399 | Follow-up months — the standing rate"Follow-Up Consultation - GLP-1 + GIP ... Priced at $399", first month $349. ⛔ The homepage's "Starting at $279" appears nowhere in the schedule at all. |
| Brand semaglutide | $1299 | Ozempic — every month"Priced at $1,299" for both the initial and the follow-up package, described as covering consultation, prescription, medication and shipping. |
| Brand tirzepatide | $1399 | Zepbound — every month"Priced at $1,399", initial and follow-up alike. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Omzo's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The full package schedule is published, itemized, in the Terms — six products with initial and follow-up prices
- Each package is stated to include the consultation, prescription, medication, shipping and ongoing support
- Unusually plain about compounding: its Terms say outright that compounded drugs are not FDA-approved and that it claims no equivalence to any approved drug
- Brand-name Ozempic and Zepbound are priced openly, at $1,299 and $1,399 a month
- States that it serves all 50 states and ships nowhere else
- Carries a LegitScript certification seal
The caveats
- ⛔ The advertised "starting at $179" is 40% below the $299 the same program's own Terms name as the standing rate
- ⛔ "Originally priced at $179, currently offered at $199" describes a price increase in the language of a markdown
- ⛔ The homepage's "$279" for tirzepatide appears nowhere in the published schedule
- The price schedule is in a legal page; nothing on the marketing pages leads a reader there
- No operating entity is named anywhere in the legal pages
- No compounding pharmacy is named
Omzo for mothers: our verdict
The homepage advertises semaglutide "starting at $179". The Terms and Conditions publish the actual schedule, and it says the follow-up months cost $299 — and that $179 is the price this program used to charge, superseded by a first month of $199. A rise written in the grammar of a discount. The tirzepatide figure is worse: the $279 on the homepage does not appear in the schedule at all, in any position. The advertised entry is $199, but the standing rate settles near $299/month — so read the headline as a starting offer, not the monthly cost.
We weigh Omzo the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What Omzo costs, in full
- Compounded semaglutide — Follow-up months — the standing rate: $199 to start, then $299/mo
- Compounded tirzepatide — Follow-up months — the standing rate: $349 to start, then $399/mo
- Brand-name semaglutide — Ozempic — every month: $1299/mo
- Brand-name tirzepatide — Zepbound — every month: $1399/mo
For context, the typical ongoing price across our roster is around $179/month, so Omzo sits at the premium end.
Omzo says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications Omzo prescribes
Omzo prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. Brand pens are available here alongside the compounded versions, and the on-label products come with the manufacturer's own pregnancy and lactation labeling — easier to hand to an OB.
Where Omzo fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
- uninterrupted nationwide access matters — a move for family shouldn't interrupt care.
Look elsewhere if…
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Everything Omzo states publicly checked out at last review: pricing, pharmacies and clinical network were all verifiable. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
One line that applies to every provider on this site: no GLP-1 is established as safe in pregnancy or while breastfeeding, and the labels advise against use. This is a review of a commercial program, not a green light — the timing decision belongs to you and your clinician.
The bottom line
Omzo is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who reads the Terms before the pricing page, and who is comparing on the $299 that follows the first month rather than the number on the banner.
Alternatives to Omzo
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing Omzo
Head-to-head & alternatives
Omzo, answered
- How much does Omzo cost?
- At last review, Omzo's lowest ongoing compounded rate was about $299 a month — $299/mo for semaglutide, $399/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Omzo safe to use while breastfeeding?
- Nothing in this class — compounded or brand — has been established as safe in pregnancy or lactation, and every label advises against use. Omzo is not an exception to that. Plan a GLP-1 for after weaning and settle the timing with your own clinician.
- Does Omzo offer both semaglutide and tirzepatide?
- Yes — Omzo offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- Where does Omzo rank for mothers?
- Omzo scores 50/100 on our Metabolic-Fit Score and sits at #88. That score is a weighted read of six things mothers actually have to care about. CoreAge Rx currently leads it — see how they compare.
Pricing, states and verification reflect Omzo's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.